Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

NCT02812641 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Stage III Esophageal Squamous Cell Carcinoma

Interventions

DRUG: BPF-CCRT (run-in)
DRUG: BPF-CCRT (randomized)
DRUG: PF-CCRT (randomized)

Sponsor

National Taiwan University Hospital